Results 211 to 220 of about 3,948,840 (323)
LUNG PUNCTURE: A NEW APPLICATION OF CLINICAL PATHOLOGY. [PDF]
ThomasJ. Horder
openalex +1 more source
Etoposide, a topoisomerase II inhibitor, reduces O‐GlcNAcylation in HepG2 liver cancer cells. Further inhibition of O‐GlcNAc transferase by OSMI‐1 enhanced etoposide‐induced apoptosis, lowering the IC50 for viability and increasing the EC50 for cytotoxicity.
Jaehoon Lee+5 more
wiley +1 more source
Associations of biological aging with the morbidity and all-cause mortality of patients with lung cancer. [PDF]
Xie Q+6 more
europepmc +1 more source
POSTOPEEATIVE MASSIVE COLLAPSE OF THE LUNGS [PDF]
Frank J. Hirschboeck
openalex +1 more source
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
L. Sequist+21 more
semanticscholar +1 more source
Comparative study of adenosine 3′‐pyrophosphokinase domains of MuF polymorphic toxins
With the ultimate goal of understanding the association of toxin‐immunity modules to temperate phages, we characterized toxins from three prophages and examined cross‐protection from immunity proteins. The toxins exhibit adenosine 3′‐pyrophosphokinase activity and are toxic in Escherichia coli.
Eloïse M. Paulet+6 more
wiley +1 more source
Exploring barriers to resilience among preoperative non-small cell lung cancer patients: a qualitative study in China. [PDF]
Guo J, Zhu J, Li X, Li W, Ye M.
europepmc +1 more source